Measure
WHO global estimates
SURVCAN-3 registries
Question
What comparable survival signal can be produced for every country?
What happened among cases recorded by participating registries?
Coverage
All 194 WHO member states
47 registries in 23 predominantly low- and middle-income countries
Patients
Ages 0–19; lymphoid leukaemia
Younger than 15; multiple childhood cancers
Period
Diagnoses during 2017–2021
Diagnoses during 2008–2017
Endpoint
Estimated five-year net survival
Reported three-year survival
Best use
Comparable worldwide baseline and starting signal
Direct benchmarks from selected registry populations